Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Millennium CEO

Executive Summary

Novartis North American oncology operations head Deborah Dunsire will succeed Mark Levin as CEO of Millennium by Aug. 1. Levin, a Millennium co-founder, will become a member of the board. Dunsire has headed Novartis' North American oncology operations since 1997; over the last eight years, the U.S. business achieved a compounded annual growth rate of 25%. Dunsire plans to take a "fresh look" at the Millennium business and will develop a strategy aimed at helping the company meet its goal of non-GAAP profitability by 2006...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS046025

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel